Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma. 31608140

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression BEFREE Intestinal mucosal tissue and polyps isolated from Mlkl<sup>-/-</sup> mice exhibited increased ERK activation and elevated expression of genes associated with inflammation and cancer. 31158430

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE Major contributions to reducing prostate cancer cell numbers included low E<sub>2</sub> concentrations producing sustained ERK phospho-activation correlated with generation of reactive oxygen species causing cancer cell death, and phospho-activation of cyclin D1 triggering its rapid degradation by interrupting cell cycle progression. 30012504

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression BEFREE These differentially abundant proteins were related to nuclear factor κB (NF-κB) and p38 mitogen-activated protein (MAP) kinase pathways and were involved in cellular compromise, inflammatory response, and cancer. 31623319

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 GeneticVariation BEFREE Two isoforms of extracellular regulated kinase (ERK), namely ERK-1 and ERK-2, are associated with several cellular processes, the aberration of which leads to cancer. 31671605

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression BEFREE The data show that ERK activation contributes to the overexpression of TIMELESS in cancer. 30629587

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression BEFREE HIF-1α-derived cell-penetrating peptides inhibit ERK-dependent activation of HIF-1 and trigger apoptosis of cancer cells under hypoxia. 30535970

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression BEFREE We demonstrate that IKKα signaling promotes increased cell malignancy of NSCLC cells as well as lung tumor progression and metastasis in either subcellular localization, through activation of common protumoral proteins, such as Erk, p38 and mTor. 30867890

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 PosttranslationalModification BEFREE Flow cytometry and western blot analysis demonstrated the fact that anticancer activity was closely related with cancer cell apoptosis and the blockade of the phosphorylation of c-Met and its downstream signaling ERK and Akt. 30503936

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE NRP-1 interacts with GIPC1 and SYX to activate p38 MAPK signaling and cancer stem cell survival. 30456845

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE ERK is a newly-identified cancer target molecule, which can significantly control COX-2 in colon cancer cells treated with TGF-β1. 31127990

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE Furthermore, KLF4 was shown to activate the p38 MAPK signaling pathway to promote cancer stemness. 29930276

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE In this review, we summarize our current understanding of the roles of the ERK and JNK pathways in controlling the Warburg effect in cancer and discuss their implication in controlling this metabolic reprogramming in physiological processes and opportunities for targeting their downstream effectors for therapeutic purposes. 30487597

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE A detailed mechanistic understanding of how p38 MAPK family members function is urgently warranted for cancer targeted therapy. 31828036

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE The findings of the present study indicated that Sirt7 affects the malignancy of glioma cells mainly in promoting glioma proliferation and invasion through ERK and STAT3 signaling. 30675198

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE Furthermore, simultaneous Fas ligation and low-dose p38 inhibition may be an effective approach for T<sub>H</sub>9 cell induction and cancer therapy. 31266950

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression BEFREE The expression of p-ERK and Mps1 in CRC with BRAF<sup>V600E</sup> was significantly higher compared with in CRC with BRAF<sup>WT</sup> (P<0.05), and their expression is associated with cancer classification, degree of differentiation and lymph node transfusion (P<0.05). 30854056

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression BEFREE Additionally, GLDCV1 increased lactate production and cancer stem cell marker expression and activated ERK and P38 pathways. 31773974

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE MAPKAPK2 (MK2), the direct substrate of p38 MAPK, has been well-acknowledged as an attractive drug target for cancer therapy. 31440466

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 AlteredExpression BEFREE In mucoepidermoid carcinomas, pERK1/ERK2 expression was associated with low-grade malignancy, positive nuclear survivin, and better disease-specific survival. 30673867

2019

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE Knockdown of BMPR1a of breast cancer cells suppresses their production of RANKL via p38 pathway and inhibits cancer-induced osteoclastogenesis, which indicates that BMPR1a might be a possible target in breast cancer-induced osteolytic metastasis. 29495003

2018

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE The nuclear translocation of the kinases p38 and JNK promotes inflammation-induced cancer. 29636389

2018

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE ERK may play a key role in α2δ1-mediated chemoresistance. mAb 1B50-1 may serve as a potential anti-SCLC drug.<i>Clin Cancer Res; 24(9); 2148-58.©2018 AACR</i>. 29437792

2018

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 Biomarker BEFREE In this study, two cancer cell lines were used to evaluate the cytotoxicity and apoptotic effect of Sg-AgNP along with the determination of the role of the Caspase-3 / p38 MAPK pathways. 29331758

2018

Entrez Id: 5594
Gene Symbol: MAPK1
MAPK1
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.100 GeneticVariation BEFREE In this issue of <i>Science Signaling</i>, Yuan <i>et al.</i> report that MEK1 homodimerization is necessary for signal transduction through the RAF-ERK pathway and that cancer-related MEK1 mutations confer enhanced dimerization and resistance to MEK inhibitors. 30377222

2018